Key result
Various pharmacological and surgical interventions, including beta-blockers and amiodarone, are utilized to prevent and treat new-onset atrial fibrillation after cardiac surgery, though inconsistencies remain in risk stratification.
Why the study?
AF is the most frequent adverse event after cardiac surgery, but inconsistencies remain regarding risk stratification, prevention, and treatment.
Population
Adult patients after cardiac surgery
Design
Review
Authors
Loading...
Persistent inconsistencies in post-cardiac surgery AF management warrant caution; review leaves open standardized risk stratification and therapies.
This review summarizes the pathophysiology, risk factors, and evidence-based prophylactic and therapeutic strategies for managing new-onset atrial fibrillation after cardiac surgery.
Burrage et al. (2019) conducted a review in New-onset atrial fibrillation after cardiac surgery (AFACS). Pharmacological and surgical prophylactic and treatment strategies was evaluated. Various pharmacological and surgical interventions, including beta-blockers and amiodarone, are utilized to prevent and treat new-onset atrial fibrillation after cardiac surgery, though inconsistencies remain in risk stratification.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: